CN103242452A - 白介素15受体片段-白介素2复合物扩增淋巴细胞的方法 - Google Patents
白介素15受体片段-白介素2复合物扩增淋巴细胞的方法 Download PDFInfo
- Publication number
- CN103242452A CN103242452A CN2013101969412A CN201310196941A CN103242452A CN 103242452 A CN103242452 A CN 103242452A CN 2013101969412 A CN2013101969412 A CN 2013101969412A CN 201310196941 A CN201310196941 A CN 201310196941A CN 103242452 A CN103242452 A CN 103242452A
- Authority
- CN
- China
- Prior art keywords
- interleukin
- cell
- mixture
- receptor fragments
- lymphocyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101969412A CN103242452A (zh) | 2013-05-22 | 2013-05-22 | 白介素15受体片段-白介素2复合物扩增淋巴细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101969412A CN103242452A (zh) | 2013-05-22 | 2013-05-22 | 白介素15受体片段-白介素2复合物扩增淋巴细胞的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103242452A true CN103242452A (zh) | 2013-08-14 |
Family
ID=48922353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101969412A Pending CN103242452A (zh) | 2013-05-22 | 2013-05-22 | 白介素15受体片段-白介素2复合物扩增淋巴细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103242452A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673750A (zh) * | 2015-02-13 | 2015-06-03 | 杭州易文赛生物技术有限公司 | 一种自然杀伤细胞扩增的方法和一种培养基组合物 |
-
2013
- 2013-05-22 CN CN2013101969412A patent/CN103242452A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673750A (zh) * | 2015-02-13 | 2015-06-03 | 杭州易文赛生物技术有限公司 | 一种自然杀伤细胞扩增的方法和一种培养基组合物 |
CN104673750B (zh) * | 2015-02-13 | 2018-04-27 | 杭州易文赛生物技术有限公司 | 一种自然杀伤细胞扩增的方法和一种培养基组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103232973B (zh) | 一种k562细胞扩增激活nk细胞的方法 | |
Vitale et al. | An historical overview: the discovery of how NK cells can kill enemies, recruit defense troops, and more | |
CN103756964B (zh) | 一种高效扩增cd3-cd56+的自然杀伤细胞培养系统的方法 | |
CN101735982A (zh) | 白介素15受体-白介素2复合物扩增淋巴细胞的方法 | |
JP6899333B2 (ja) | 汎用キラーt細胞 | |
CN102597223B (zh) | 生产天然杀伤细胞的方法 | |
CN105624107B (zh) | 一种多种淋巴细胞亚群的扩增方法及其应用 | |
Gong et al. | Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co‐express major histocompatibility complex class I chain‐related protein A, 4‐1BB ligand, and interleukin‐15 | |
CN103502438A (zh) | 用于细胞免疫治疗的方法和组合物 | |
CN106795221A (zh) | 用于癌症免疫治疗的cd33特异性嵌合抗原受体 | |
Sadelain | Chimeric antigen receptors: a paradigm shift in immunotherapy | |
CN105848484A (zh) | 用于免疫治疗的多克隆γδ T细胞 | |
CN102676453A (zh) | 一种nk和/或nkt细胞的培养方法 | |
CN105567634A (zh) | 一种用于nk细胞体外扩增的培养基及nk细胞体外扩增的方法 | |
CN109536455B (zh) | 一种car-nk细胞及其制备方法和应用 | |
CN109797171A (zh) | 经修饰的t细胞、其制备方法及用途 | |
Burga et al. | Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells | |
CN109652378A (zh) | 一种功能增强的通用型car-t细胞及其制备方法和用途 | |
CN105296431A (zh) | 肿瘤结合特异性γδTCR基因修饰的αβT细胞及其抑癌用途 | |
CN109722437A (zh) | 一种通用型car-t细胞及其制备方法和用途 | |
CN115558641B (zh) | 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用 | |
CN102027104A (zh) | 含有细胞因子诱导杀伤细胞的细胞群的制造方法 | |
Levy et al. | RNA-seq analysis reveals CCR5 as a key target for CRISPR gene editing to regulate in vivo NK cell trafficking | |
Wang et al. | Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential | |
Khorasani et al. | CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU ZHONGYING TECHNOLOGY GROUP CO., LTD. Free format text: FORMER OWNER: ZHEJIANG ZHONGYING HOLDING GROUP CO., LTD. Effective date: 20130830 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310000 HANGZHOU, ZHEJIANG PROVINCE TO: 310052 HANGZHOU, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130830 Address after: 310052 No. 88 Chutian Road, Hangzhou, Zhejiang, Binjiang District Applicant after: Hangzhou Zhongying Technology Group Co., Ltd. Address before: 310000 No. 88 Chutian Road, Hangzhou, Zhejiang, Binjiang District Applicant before: Zhongying Holding Group Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU ZHONGYING BIOLOGICAL MEDICAL TECHNOLOGY C Free format text: FORMER OWNER: HANGZHOU ZHONGYING TECHNOLOGY GROUP CO., LTD. Effective date: 20140314 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140314 Address after: 310052 No. 88 Chutian Road, Hangzhou, Zhejiang, Binjiang District Applicant after: Hangzhou Zhongying bio-medical technology limited company Address before: 310052 No. 88 Chutian Road, Hangzhou, Zhejiang, Binjiang District Applicant before: Hangzhou Zhongying Technology Group Co., Ltd. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130814 |